NCT05879627 2026-04-13
To Evaluate the Safety, Tolerance and Pharmacokinetics of BAT8007 for Injection in Patients With Advanced Solid Tumors
Bio-Thera Solutions
Phase 1 Terminated
Bio-Thera Solutions
Jiangsu Simcere Pharmaceutical Co., Ltd.
Hervor Therapeutics
Debiopharm International SA
Incyte Corporation
HRYZ Biotech Co.